<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04260595531280</udiDi>
    <basicUdiDi>B-04260595531280</basicUdiDi>
    <tradeName>Bepanthene® Gotas Oftálmicas</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41090801L</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:28.255Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531273</udiDi>
    <basicUdiDi>B-04260595531273</basicUdiDi>
    <tradeName>Bepanthene® Gotas Oftálmicas (Amostra)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41087500L</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:26.476Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531266</udiDi>
    <basicUdiDi>B-04260595531266</basicUdiDi>
    <tradeName>Bepanthene® Eye Drops</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41105101L</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:25.565Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531259</udiDi>
    <basicUdiDi>B-04260595531259</basicUdiDi>
    <tradeName>Bepanthene® Eye Drops</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41105201L</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:23.759Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531242</udiDi>
    <basicUdiDi>B-04260595531242</basicUdiDi>
    <tradeName>Bepanthene® Eye Drops (sample)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41105300L</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:22.859Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531228</udiDi>
    <basicUdiDi>B-04260595531228</basicUdiDi>
    <tradeName>Bepanthen® Eye silmätipat</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41112800L</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:21.090Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531211</udiDi>
    <basicUdiDi>B-04260595531211</basicUdiDi>
    <tradeName>Bepanthen® Eye silmätipat</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41089800L</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:20.151Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531204</udiDi>
    <basicUdiDi>B-04260595531204</basicUdiDi>
    <tradeName>Bepanthen® Eye silmätipat</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41090401L</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:18.352Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531198</udiDi>
    <basicUdiDi>B-04260595531198</basicUdiDi>
    <tradeName>Bepanthen® Eye silmätipat</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41090101L</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:17.459Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531181</udiDi>
    <basicUdiDi>B-04260595531181</basicUdiDi>
    <tradeName>Bepanthen Eye® silmatilgad</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41108500L</reference>
    <placedOnMarketCountry>Estonia</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:15.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531174</udiDi>
    <basicUdiDi>B-04260595531174</basicUdiDi>
    <tradeName>Bepanthen Eye® silmatilgad</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41090501L</reference>
    <placedOnMarketCountry>Estonia</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:14.766Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531167</udiDi>
    <basicUdiDi>B-04260595531167</basicUdiDi>
    <tradeName>Bepanthen® Eye Krople do oczu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41089900L</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:12.950Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531150</udiDi>
    <basicUdiDi>B-04260595531150</basicUdiDi>
    <tradeName>Bepanthen® Eye Krople do oczu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41090701L</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:12.048Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531082</udiDi>
    <basicUdiDi>B-04260595531082</basicUdiDi>
    <tradeName>Bepanthen® Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41099300L</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:10.255Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531075</udiDi>
    <basicUdiDi>B-04260595531075</basicUdiDi>
    <tradeName>Bepanthen® Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41091100L</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:09.344Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531068</udiDi>
    <basicUdiDi>B-04260595531068</basicUdiDi>
    <tradeName>Bepanthen® 
Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41096500L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:07.552Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531051</udiDi>
    <basicUdiDi>B-04260595531051</basicUdiDi>
    <tradeName>Bepanthen® Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41083900L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:06.651Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531044</udiDi>
    <basicUdiDi>B-04260595531044</basicUdiDi>
    <tradeName>Bepanthen® 
Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41090301L</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:04.850Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531037</udiDi>
    <basicUdiDi>B-04260595531037</basicUdiDi>
    <tradeName>Bepanthen® 
Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41083801L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:03.953Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595531020</udiDi>
    <basicUdiDi>B-04260595531020</basicUdiDi>
    <tradeName>Bepanthen® Augentropfen (Muster)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41087000L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:52:02.141Z</lastUpdated>
  </row>
</eudamedExport>